I have no hard data (and I don't think anyone has, at this point), but eradication is IMO going to be tricky even if we have a very potent vaccine, at least looking at how much it took for chicken pox.
But I'm optimistic, the current situation has everyone focused on the issue. Except Trump trying to get some special deals for early access or whatever the fuck it is that he's doing.
As an example, Moderna teamed up with Lonza (and also got a big grant from BARDA). Oxford / Vaccitech has deals with Astra Zeneca, Merck, and a few other manufacturers.